Futures Prices (%) Futures By : MS Money Moves PT= Price target (i.e our approximate exit price)Unless stated otherwise, the price next to the ticker is a suitable entry price. An … [Read more...] about Trade-Ideas, Friday, Jan. 17th, 2020
Monday morning kicks off one of the largest biotech events of the year: the JP Morgan Healthcare Conference. This conference is a four day event of the "who's who" in the world of biotech. Here, … [Read more...] about Big Week for Bio: JP Morgan Healthcare Conference
On September 25th, 2019 the MS Money Moves Executive Leadership Team had an hour long conference call with President and CEO of DelMar Pharmaceuticals (Nasdaq: DMPI) Saiid Zarrabian and acting Chief … [Read more...] about Introducing the New and Improved DelMar Pharmaceuticals (Nasdaq: DMPI)
MTNB buy $1.53-1.60 Institutional investors are loading up following the JPM conference this week.PT= $2.50FYI I (Sultan) sold 1/4 of my position in LJPCLets's get this bread … [Read more...] about MTNB Buy Alert
I previously posed an investment thesis for Seattle Genetics (SGEN) published here at MS Money Moves on May 24th, when the share price was $69.11. Seattle Genetics closed trading on December 24th at … [Read more...] about Seattle Genetics: Initial Expectations for Enfortumab Vedotin
(BTFD = Buy The F$%#$ng Dip) NGM is down on low volume attributable to bold short sellers. The stock has not left its channel beginning in November 2019. In our view, shares are being offered … [Read more...] about NGM BTFD!
A few months ago, DelMar Pharmaceuticals (NASDAQ: DMPI) caught our attention as a mischaracterized turn-around story in the making. After digging I found that much of DelMar’s competition have failed … [Read more...] about DelMar Pharmaceuticals (Nasdaq: DMPI) Bull Case is Reinforced by Positive Data Update